US Broker Ratings

Bio-Techne Corp (TECH) Investor Outlook: Analyzing a 41.61% Potential Upside Amid Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH) is a noteworthy player in the biotechnology sector, offering a mix of life science reagents, instruments, and services. Headquartered in Minneapolis, Minnesota, the company operates through..

The Ensign Group, Inc. (ENSG) Stock Analysis: An 8.39% Upside in the Healthcare Sector

The Ensign Group, Inc. (ENSG), a stalwart in the healthcare sector, with a focus on medical care facilities, is capturing the attention of investors with its potential for growth and..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a 26% Potential Upside in Healthcare Plans

Oscar Health, Inc. (NYSE: OSCR) presents an intriguing opportunity for investors looking to tap into the healthcare sector, particularly within the realm of healthcare plans. As a company that operates..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Evaluating Growth Amidst a 4.04% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. The company, headquartered in Tarrytown, New..

Chemed Corp (CHE) Stock Analysis: A 20% Upside Potential in the Healthcare Sector

Chemed Corp (CHE), a prominent player in the healthcare sector, offers a unique mix of hospice care and commercial services through its VITAS and Roto-Rooter segments. With a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Closer Look at Valuation and Growth Prospects in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a leading player in the global pharmaceutical industry, presents a compelling case for investors with its robust revenue growth and strategic positioning in the..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a 31% Potential Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), operating within the dynamic healthcare sector, has garnered significant attention from investors due to its robust presence in the medical instruments and supplies industry. With a..

Integer Holdings Corporation (ITGR) Stock Analysis: Healthcare Growth with a 22.6% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, operates as a contract development and manufacturing company specializing in medical devices. With a market capitalization of $4.23..

Vaxcyte, Inc. (PCVX) Investor Outlook: Analyzing a 239.96% Potential Upside

Vaxcyte, Inc. (NASDAQ: PCVX), a promising player in the biotechnology sector, has caught the eye of investors with a remarkable potential upside of 239.96%. This clinical-stage vaccine innovation company is..

BeOne Medicines Ltd. (ONC): Investor Outlook on a Biotech Powerhouse with 29.81% Upside Potential

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is catching the attention of investors with a compelling potential upside of 29.81% as per analyst ratings. Based in..

Nuvalent, Inc. (NUVL): Biotechnology Innovator with a 44% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is garnering significant attention within the biotechnology sector. With a robust market capitalization of $5.6 billion, Nuvalent is..

Molina Healthcare Inc (MOH) Stock Analysis: Potential 20.98% Upside Amid Strong Growth and Analyst Confidence

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is garnering significant attention from investors due to its robust performance metrics and attractive growth potential. With..

Avidity Biosciences, Inc. (RNA) Investor Outlook: An 84% Potential Upside with Innovative Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing investor attention in the biotechnology sector with a promising potential upside of 84.29%, driven by its innovative approach in RNA therapeutics. As a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Healthcare Giant with a 9.56% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands out in the bustling healthcare sector as a key player in the medical devices industry. With a solid market capitalization of $13.24..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unpacking the 76% Potential Upside

Revolution Medicines, Inc. (RVMD), a trailblazer in the biotechnology industry, focuses on the development of innovative therapies targeting RAS-addicted cancers. With a market capitalization of $7.65 billion, this clinical-stage precision..

Exact Sciences Corporation (EXAS) Investor Outlook: Exploring a 25.51% Potential Upside

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically within diagnostics and research, continues to attract investor interest. With a market capitalization of $10.35 billion, the..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unpacking the 43% Potential Upside for Investors

For investors with a keen eye on the healthcare sector, Bio-Rad Laboratories, Inc. (NYSE: BIO) represents an intriguing opportunity. With a market capitalization of $6.05 billion, this U.S.-based company operates..

Medpace Holdings (MEDP) Stock Analysis: Navigating a 65.83% ROE in the Healthcare Sector

Investors eyeing the healthcare sector often consider companies that exhibit strong financial performance and a robust market presence. Medpace Holdings, Inc. (NASDAQ: MEDP), a clinical contract research organization, stands out..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 13.92% Potential Upside in the Medical Devices Sector

Merit Medical Systems, Inc. (NASDAQ: MMSI) is gaining attention in the healthcare sector, particularly among investors seeking opportunities in medical instruments and supplies. With a market cap of $5.63 billion,..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 17.63% Potential Upside Amid Strong Buy Ratings

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, offers a compelling investment opportunity with an impressive potential upside of 17.63%. Amid a robust buy consensus..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds